IND-Enabling programs for gene therapies

Gene therapies continue to hold promise as treatments for many diseases but there are numerous and unique challenges to developing them for submission as an Investigational New Drug (IND)/ Investigational Medicinal Product Dossier (IMPD) application for use in clinical trials. These applications require an optimized scientific program designed to address the scientific, regulatory and practical challenges of gene therapy development.

Copy and paste this URL:

https://pub-stage.drugdevelopment.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/Blog/dna%20blog%20header%204.jpg